We will continue to consider ways to reduce the role of hospital chargemasters in Medicare IPPS payments, as we described in the CY 2026 OPPS/ASC proposed rule, to further reflect market-based approaches in Medicare FFS payments, to the extent permitted by law
Is AOD 9604 legal and FDA-approved
Schedule your consultation today and take the next step toward renewed energy and improved well-being
Pressure-induced changes in the structure and function of the kinesin-microtubule complex
Athletes are constantly seeking ways to optimize recovery, performance, and health, but the marketplace is crowded with products that may contain unapproved drugs, contaminants, or undisclosed ingredients
We are not approving the aprevo Cervical ACDF System for transitional pass-through payment status for CY 2026 because the technology does not meet the device category eligibility criterion at 419.66(c)(1)